RE:Ixinity replacement therapyHow much they've spent on ixinity? A lot,
https://hemophilianewstoday.com/news/in-potential-100m-deal-medexus-acquires-global-rights-to-ixinity-hemophilia-b-therapy/
Rasuvu facing competition, paid a lot
Treosulfan agreement is not a small number, Will it up for challenge? Yes, the generic drug, busulfan, manufactured by medac, before
When you have only a fewand all eggs in a basket, the danger is obvious